top of page

Current Portfolio

Oticara is a specialty pharmaceutical company selling improved anti-fungal products for diseases with underserved medical needs.

SageMedic develops technology to 3D-print patient tumors for directed genome testing, determining the safest treatment options for patients.
Past Investments & Exits
bottom of page